Science
Nanoparticle Design Paves Way for Improved Detection of Tumors – Novus Light Today – Novus Light Technologies Today
A research team from KTH Royal Institute of Technology is combining optical and X-ray fluorescence contrast agents into a single enhancer for both modes.
In order to enhance visual contrast of living tissues, state-of-the-art imaging relies on agents such as fluorescent dyes and biomolecules. Advances in nanoparticle research have expanded the array of promising contrast agents for more targeted diagnostics, and now a research team from KTH Royal Institute of Technology has raised the bar further yet. They are combining optical and X-ray fluorescence contrast agents into a single enhancer for both modes.
Muhammet Toprak, Professor of Materials Chemistry…
-
Noosa News16 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
Business19 hours agoWhy you should sell CBA, Lynas, and Tabcorp shares today
-
Business18 hours agoDroneShield announces new $13 million counter-drone facility as employees top 400
-
General14 hours agoRescuers pull children from the rubble of Indonesian boarding school collapse